The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Hypophagia 6
SANDOSTATIN LAR DEPOT Induration 6
SANDOSTATIN LAR DEPOT Inner ear disorder 6
SANDOSTATIN LAR DEPOT Local swelling 6
SANDOSTATIN LAR DEPOT Malnutrition 6
SANDOSTATIN LAR DEPOT Menstrual disorder 6
SANDOSTATIN LAR DEPOT Metabolic disorder 6
SANDOSTATIN LAR DEPOT Metastasis 6
SANDOSTATIN LAR DEPOT Muscle rupture 6
SANDOSTATIN LAR DEPOT Neuralgia 6
SANDOSTATIN LAR DEPOT Neuroendocrine tumour 6
SANDOSTATIN LAR DEPOT Nosocomial infection 6
SANDOSTATIN LAR DEPOT Oral candidiasis 6
SANDOSTATIN LAR DEPOT Pancreatic neoplasm 6
SANDOSTATIN LAR DEPOT Poor quality sleep 6
SANDOSTATIN LAR DEPOT Pre-eclampsia 6
SANDOSTATIN LAR DEPOT Premature labour 6
SANDOSTATIN LAR DEPOT Presyncope 6
SANDOSTATIN LAR DEPOT Procedural complication 6
SANDOSTATIN LAR DEPOT Product leakage 6

Total Records: 2,045     Number of Pages: 103